Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TRKB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TRKB is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with ALS, Aging, Als. Connected to 362 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TRKB |
| Chromosome | 9q21.33 |
| Protein Type | Receptor |
| Function | is a high-affinity receptor tyrosine kinase that serves as the primary signaling receptor for brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4). |
| Subcellular Localization | </th><td>Cell membrane, endosomes, nucleus, mitochondria</td></tr> |
| Molecular Weight | 140 kDa |
| Amino Acids | 796 aa |
| Exons | 24 |
| Pathways | Akt, Apoptosis, Cell Cycle, Long-Term Potentiation, Mapk |
| UniProt ID | Q16620 |
| NCBI Gene ID | 4915 |
| Ensembl ID | ENSG00000148053 |
| GeneCards | TRKB |
| Human Protein Atlas | TRKB |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer'S Disease, Cancer |
| Interactions | ACHE, Actin, ADAM10, AEP, AGING, AKT |
| KG Connections | 925 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
BDNF["BDNF
Brain-Derived
Neurotrophic Factor"]
TRKB["TRKB
Tropomyosin Receptor
Kinase B"]
FGF7["FGF7
Fibroblast Growth
Factor 7"]
Neurodegeneration["Neurodegeneration
General Process"]
Alzheimer["Alzheimer's
Disease"]
Parkinson["Parkinson's
Disease"]
ALS["Amyotrophic Lateral
Sclerosis (ALS)"]
MS["Multiple
Sclerosis"]
Depression["Depression
Mood Disorder"]
Stroke["Stroke
Cerebrovascular
Event"]
Ischemia["Ischemia
Reduced Blood
Flow"]
Aging["Aging
Process"]
Inflammation["Inflammation
Immune Response"]
Fibrosis["Fibrosis
Tissue Scarring"]
NeuroprotectiveEffects["Neuroprotective
Effects"]
TissueRepair["Tissue Repair
and Regeneration"]
BDNF -->|"activates"| TRKB
TRKB -->|"regulates"| FGF7
TRKB -->|"promotes"| NeuroprotectiveEffects
TRKB -->|"enhances"| TissueRepair
TRKB -->|"therapeutic_target"| Neurodegeneration
TRKB -->|"therapeutic_target"| Alzheimer
TRKB -->|"therapeutic_target"| Parkinson
TRKB -->|"therapeutic_target"| ALS
TRKB -->|"therapeutic_target"| MS
TRKB -->|"therapeutic_target"| Depression
TRKB -->|"inhibits"| Aging
TRKB -->|"inhibits"| Fibrosis
TRKB -->|"regulates"| Inflammation
Ischemia -->|"leads_to"| Stroke
Aging -->|"contributes_to"| Neurodegeneration
style TRKB fill:#006494
style BDNF fill:#1b5e20
style NeuroprotectiveEffects fill:#1b5e20
style TissueRepair fill:#1b5e20
style FGF7 fill:#4a1a6b
style Neurodegeneration fill:#ef5350
style Alzheimer fill:#ef5350
style Parkinson fill:#ef5350
style ALS fill:#ef5350
style MS fill:#ef5350
style Aging fill:#5d4400
style Depression fill:#5d4400
style Stroke fill:#5d4400
style Inflammation fill:#ef5350
style Fibrosis fill:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| BDNF | activates | gene | 1.00 |
| Synaptic Plasticity | activates | pathway | 1.00 |
| Inflammation | activates | disease | 0.95 |
| Depression | activates | disease | 0.95 |
| Aging | activates | disease | 0.95 |
| BDNF signaling | activates | pathway | 0.92 |
| PLC/IP3 pathway | activates | pathway | 0.90 |
| PI3K | interacts_with | gene | 0.90 |
| PI3K | interacts_with | protein | 0.90 |
| Neurotrophic Signaling | involved_in | pathway | 0.90 |
| AKT | activates | gene | 0.90 |
| DEPRESSION | activates | gene | 0.90 |
| ERK | activates | protein | 0.88 |
| Depression | therapeutic_target | disease | 0.85 |
| Neurodegeneration | activates | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Als | regulates | disease | 0.85 |
| CREB | phosphorylates | protein | 0.85 |
| synaptic protein expression | regulates | process | 0.80 |
| DEPRESSION | therapeutic_target | gene | 0.80 |
| AGING | activates | gene | 0.80 |
| BDNF | therapeutic_target | gene | 0.80 |
| Neurogenesis | activates | pathway | 0.80 |
| TNF-Α | activates | gene | 0.80 |
| P75NTR | activates | gene | 0.80 |
| Als | inhibits | disease | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Diabetes | activates | disease | 0.75 |
| Alzheimer | therapeutic_target | disease | 0.75 |
| Neuroinflammation | activates | disease | 0.75 |
| Stroke | activates | disease | 0.75 |
| Ischemia | activates | disease | 0.75 |
| JAK | activates | gene | 0.70 |
| Pi3K/Akt | activates | pathway | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| Differentiation | activates | pathway | 0.70 |
| Microbiota | activates | pathway | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| INFLAMMATION | therapeutic_target | gene | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| NEUROINFLAMMATION | activates | gene | 0.70 |
| acute lung injury | treats | disease | 0.70 |
| Oxidative Stress | regulates | pathway | 0.70 |
| EXERCISE | activates | gene | 0.70 |
| FGF7 | regulates | protein | 0.70 |
| Apoptosis | regulates | pathway | 0.70 |
| BDNF | causes | gene | 0.70 |
| AKT | inhibits | gene | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BDNF | activates | protein | 1.00 |
| BDNF | associated_with | gene | 1.00 |
| LSD | binds_to | drug | 0.95 |
| psilocin | binds_to | drug | 0.95 |
| BDNF | binds_to | protein | 0.95 |
| Exercise Training | upregulates | process | 0.93 |
| AMYLOID BETA | degrades | protein | 0.90 |
| BDNF | expresses | gene | 0.90 |
| BDNF | activates | protein | 0.90 |
| TNF | activates | gene | 0.90 |
| BDNF | binds | gene | 0.80 |
| ABETA | inhibits | protein | 0.80 |
| NEURODEGENERATION | activates | gene | 0.80 |
| PI3K | activates | gene | 0.80 |
| BDNF | interacts_with | protein | 0.72 |
| TAU | therapeutic_target | gene | 0.70 |
| EXERCISE | activates | gene | 0.70 |
| ANA-12 | inhibits | drug | 0.70 |
| 7,8-DHF | activates | drug | 0.70 |
| BDNF | regulates | gene | 0.70 |
| STROKE | activates | gene | 0.70 |
| IL-6 | activates | gene | 0.70 |
| ERK | activates | gene | 0.70 |
| BDNF | interacts_with | protein | 0.70 |
| HUNTINGTON | associated_with | gene | 0.70 |
| EPILEPSY | associated_with | gene | 0.70 |
| DEPRESSION | associated_with | gene | 0.70 |
| BAX | causes | gene | 0.60 |
| BAD | causes | gene | 0.60 |
| NPY | activates | gene | 0.60 |
| NGF | activates | gene | 0.60 |
| PSD95 | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| SLC17A7 | expressed_in | gene | 0.60 |
| RAB7 | expressed_in | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| RAB5 | expressed_in | gene | 0.60 |
| CACNA1G | expressed_in | gene | 0.60 |
| CALB1 | expressed_in | gene | 0.60 |
| RAB11 | expressed_in | gene | 0.60 |
| NPY | inhibits | gene | 0.60 |
| SIGMAR1 | inhibits | gene | 0.60 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.60 |
| INFLAMMATION | regulates | gene | 0.60 |
| NF-ΚB | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | protects_against | gene | 0.60 |
| TAU PATHOLOGY | protects_against | gene | 0.60 |
| MIRNAS | regulates | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Activity-Dependent Synaptic Tagging via CREB-BDNF-TrkB Signa | 0.610 | synaptic biology | What determines the selectivity of compl |
| HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks enhances hip | 0.450 | neurodegeneration | What are the optimal oxygen pressure, du |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TRKB in their description or question text
No additional research found